Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...
Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...
A single tick bite can reprogram the immune system and trigger an allergy to red meat, scientifically known as alpha-gal ...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions The latest update is out from Genprex ( (GNPX) ). On January 6, 2026, Genprex reported positive preliminary ...
Syngas biomethanation—converting CO/CO₂/H₂ into renewable methane—relies on coordinated microbial interactions. This study reveals that excess ...
Cancer immunotherapy has proven efficacy in some cancer subtypes but it often fails to deliver clinically meaningful benefits to patients because their tumors are poorly immunogenic. A major goal of ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
For the most part, we’re fans of Roku’s friendly, intuitive remotes, and particularly the ones that have voice capabilities. But there’s a sticking point—four of them, actually—when it comes to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback